HomeNDC LookupRxCUI directory › RxCUI 310191

Estradiol valerate 40 MG/ML Injectable Solution — RxCUI 310191

RxNorm drug concept · Semantic clinical drug
RxCUI 310191 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310191
Official nameEstradiol valerate 40 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)105,764 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Estradiol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's designed to ease the moderate to severe hot flashes and night sweats that come with menopause. When estrogen levels drop after menopause, your body's hormonal signals go a bit...
  • What exactly is this medication supposed to do for me?
  • Apply it to your upper thigh — alternating right and left sides each day — and spread it over an area roughly the size of two palm prints. Let it dry completely before getting dres...
  • How do I use the gel correctly so it actually works?
📖 Read our full Estradiol Topical guide →

🕸️ Concept Web — How Estradiol valerate 40 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Estradiol valerate 40 MG/ML Injectable Solution RxCUI 310191

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Estradiol 4083
    • Estradiol valerate 24395
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Delestrogen 319865
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Estradiol Injectable Solution 142249
    • Estradiol valerate Injectable Solution 2646951
    • Estradiol Injectable Product 1165183
    • Estradiol valerate Injectable Product 2659528
    • Estradiol Injectable Solution [Delestrogen] 362704
    • Estradiol valerate Injectable Solution [Delestrogen] 2657912
    • Delestrogen Injectable Product 1171689
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Estradiol valerate 40 MG/ML 1791182
    • Estradiol valerate 40 MG/ML Injectable Solution [Delestrogen] 206813
    • Estradiol valerate 40 MG/ML [Delestrogen] 1791184

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Estradiol valerate 40 MG/ML SCDC · 1791182
  • Estradiol Injectable Solution SCDF · 142249
  • Estradiol valerate Injectable Solution SCDFP · 2646951
  • Estradiol Injectable Product SCDG · 1165183
  • Estradiol valerate Injectable Product SCDGP · 2659528

Brand-Name Concepts

  • Estradiol valerate 40 MG/ML Injectable Solution [Delestrogen] SBD · 206813
  • Estradiol valerate 40 MG/ML [Delestrogen] SBDC · 1791184
  • Estradiol Injectable Solution [Delestrogen] SBDF · 362704
  • Estradiol valerate Injectable Solution [Delestrogen] SBDFP · 2657912
  • Delestrogen Injectable Product SBDG · 1171689
  • Delestrogen BN · 319865

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 310191 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9289-01 1 VIAL in 1 CARTON (0143-9289-01) / 5 mL in 1 VIAL Estradiol Valerate Hikma Pharmaceuticals USA Inc. 2020-04-21
00143-9290-01 1 VIAL in 1 CARTON (0143-9290-01) / 5 mL in 1 VIAL Estradiol Valerate Hikma Pharmaceuticals USA Inc. 2020-04-21
00143-9291-01 1 VIAL in 1 CARTON (0143-9291-01) / 5 mL in 1 VIAL Estradiol Valerate Hikma Pharmaceuticals USA Inc. 2020-04-21
00517-0420-01 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0420-01) / 5 mL in 1 V... ESTRADIOL VALERATE American Regent, Inc. 2020-03-01
00517-0440-01 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0440-01) / 5 mL in 1 V... ESTRADIOL VALERATE American Regent, Inc. 2020-03-01
70700-0273-22 5 mL in 1 VIAL, MULTI-DOSE (70700-273-22) Estradiol valerate Xiromed, LLC 2023-05-01
70700-0274-22 5 mL in 1 VIAL, MULTI-DOSE (70700-274-22) Estradiol valerate Xiromed, LLC 2023-05-01
70700-0275-22 5 mL in 1 VIAL, MULTI-DOSE (70700-275-22) Estradiol valerate Xiromed, LLC 2023-05-01
Observed labelers: Hikma Pharmaceuticals USA Inc. (3) · Xiromed, LLC (3) · American Regent, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1380 Estradiol valerate 10 mg inj 8 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.